SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-006584
Filing Date
2022-06-15
Accepted
2022-06-15 16:15:38
Documents
2
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 form3-06152022_010626.html 3  
1 form3-06152022_010626.xml 3 3093
2 ex24-06152022_010626.htm EX-24 8396
  Complete submission text file 0001415889-22-006584.txt   12970
Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E., SUITE 310 SEATTLE WA 98102
Business Address
Yurasov Sergey (Reporting) CIK: 0001686295 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 221017940

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)